MCM
ELV icon

Mazama Capital Management’s Elevance Health ELV Stock Holding History

Mazama Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-9,015
Closed -$1.13M – 280
2014
Q4 		$1.13M Sell
9,015
-19,353
-68% -$2.39M 0.26% 114
2014
Q3 		$3.39M Buy
+28,368
New +$3.25M 0.86% 38

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Mazama Capital Management's ELV Position: Q1 2015 in Review

Mazama Capital Management sold out of Elevance Health (ELV) in Q1 2015, closing a stake of 9,015 shares — an estimated $1.13M sold.

Mazama Capital Management first reported a position in ELV in Q3 2014 and held it in 2 quarters. The position peaked at $3.39M in Q3 2014. 753 funds tracked by Wall St. Rank hold ELV as of Q1 2015.

  • Mazama Capital Management reported no remaining Elevance Health position as of Q1 2015 after selling out during the quarter.
  • Mazama Capital Management sold 9,015 Elevance Health shares in Q1 2015, an estimated $1.13M.
  • Mazama Capital Management first reported a position in Elevance Health in Q3 2014 and held it in 2 quarters.
  • Mazama Capital Management's Elevance Health position peaked at $3.39M in Q3 2014.
  • 753 funds tracked by Wall St. Rank held Elevance Health as of Q1 2015.

Based on Mazama Capital Management's 13F filing for Q1 2015, filed 15 May 2015.